Knowledge Hub

Global Ebolavirus Infections (Ebola Hemorrhagic Fever) Market Shares, Strategies, And Forecasts Clinical Trials Review, H2, 2016

Press Release   •   Nov 18, 2016 05:17 EST

GlobalData's clinical trial report, Ebolavirus Infections (Ebola Hemorrhagic Fever) Global Clinical Trials Review, H2, 2016" provides an overview of Ebolavirus Infections (Ebola Hemorrhagic Fever) clinical trials scenario. This report provides top line data relating to the clinical trials on Ebolavirus Infections (Ebola Hemorrhagic Fever). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

View Report At :


- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

Download Sample copy of this Report at :

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Clinical Trials by G7 Countries: Proportion of Ebolavirus Infections (Ebola Hemorrhagic Fever) to Infectious Disease Clinical Trials 14

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Ebolavirus Infections (Ebola Hemorrhagic Fever) to Infectious Disease Clinical Trials 18

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Subjects Recruited Over a Period of Time 25

Clinical Trials by Sponsor Type 26

Prominent Sponsors 27

Top Companies Participating in Ebolavirus Infections (Ebola Hemorrhagic Fever) Therapeutics Clinical Trials 28

Prominent Drugs 30

Latest Clinical Trials News on Ebolavirus Infections (Ebola Hemorrhagic Fever) 31

Oct 04, 2016: RespireRx Pharmaceuticals Retracts Efficacy Data in September 12, 2016 Press Release Announcing Preliminary Top-Line Analysis of Safety and Efficacy Data from Duke University Phase 2A Clinical Trial of CX 1739 31

Sep 07, 2016: BioCryst Announces Positive Study Results for BCX4430 Delayed Treatment of Ebola Virus Infection in a Non-Human Primate Model 31

Aug 24, 2016: Experts at World Congress of Internal Medicines Reinforce Importance of BETADINE in Disease Prevention, Infection Control and Oral Mucositis Treatment 31

Aug 11, 2016: Inovio Pharmaceuticals Expands Positive Phase I Ebola Vaccine Trial to Identify Most Optimal Immunization Regimen 32

Jul 28, 2016: Ranpirnase Shows Antiviral Effect Against Ebola 33

Jul 18, 2016: Soligenix Announces Presentation of Positive Preliminary Results of a Heat Stable Ebola Vaccine Formulation 33

Jul 14, 2016: Yisheng Biopharma and the United States Army Medical Research Institute of Infectious Diseases Announce Positive Animal Results of Vaccine Against Ebola Virus 35

Clinical Trial Profile Snapshots 36

Appendix 88

Abbreviations 88

Definitions 88

Research Methodology 89

Secondary Research 89

About GlobalData 90

Contact Us 90

Disclaimer 90

Source 91

Follow us on LinkedIn: is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.